Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy.

Interestingly, the overall number of negative predictors was lower (median 2.0, range 0–5) in individuals with SVR versus patients with virologic failure (median 3.0, range 1–5) and this was highly significant ( Fig 4A , P <0.0001).

also in 132,142 other papers